You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Calcineurin-inhibitor nephrotoxicity (CIN)

Showing 1 - 25 of 7,870
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Disorder Related to Renal Transplantation Trial in Odense C (Spironolactone, )

Completed
  • Disorder Related to Renal Transplantation
  • Odense C, Denmark
    Odense University Hospital
Sep 8, 2021

Lung Transplant; Complications Trial in Nashville (Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate

Not yet recruiting
  • Lung Transplant; Complications
  • Tacrolimus Extended Release Oral Tablet [Envarsus]
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 6, 2022

Renal Transplant Trial in Toledo (Arm 1 Everolimus/Reduced dose tacrolimus)

Completed
Has Results
  • Renal Transplant
  • Arm 1 Everolimus/Reduced dose tacrolimus
  • Toledo, Ohio
    University of Toledo, Health Science Campus
May 2, 2022

Transplant, Liver Trial in Charlotte (Spironolactone)

Completed
Has Results
  • Transplant, Liver
  • Charlotte, North Carolina
    CHS
Apr 19, 2022

Chronic Kidney Failure Trial in Nantes (Belatacept 250 Milligram Intravenous Powder for Solution)

Not yet recruiting
  • Chronic Kidney Failure
  • Belatacept 250 Milligram Intravenous Powder for Solution
  • Nantes, Loire Atlantique, France
    CHU Nantes
Sep 28, 2022

Renal Transplantation Trial in San Francisco (sirolimus)

Completed
Has Results
  • Renal Transplantation
  • San Francisco, California
    California Pacific Medical Center; Barry S. Levin, MD Department
Oct 2, 2020

Long-term Follow-up of Spare the Nephron (STN) Patients

Completed
  • Kidney Transplant
    • Baltimore, Maryland
      University of Maryland Medicine, Division of Adult Nephrology
    Feb 25, 2022

    Prevalent Kidney Transplant Recipients Using Torque Teno Virus:

    Not yet recruiting
    • Kidney Transplant Infection
    • +2 more
    • Torque teno virus DNA measurement
    • (no location specified)
    Apr 19, 2023

    Dermatomyositis, Adult Type, Interstitial Lung Disease Trial in Nanjing (triple therapy, dual-therapy)

    Recruiting
    • Dermatomyositis, Adult Type
    • Interstitial Lung Disease
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    May 20, 2022

    End Stage Renal Disease, Rejection of Renal Transplant Trial in Chicago (Tacrolimus, Tacrolimus Extended Release Oral Tablet

    Completed
    • End Stage Renal Disease
    • Rejection of Renal Transplant
    • Tacrolimus
    • Tacrolimus Extended Release Oral Tablet [Envarsus]
    • Chicago, Illinois
      Northwestern University
    Jan 12, 2023

    Renal Transplantation; Complication Trial in Alexandria (serum magnesium level, FEMg)

    Not yet recruiting
    • Renal Transplantation; Complication
    • serum magnesium level, FEMg
    • Alexandria, Egypt
      Faculty of Medicine, Aexandria University
    Apr 25, 2022

    GVHD, Malignancy Trial in Canada, United States (Abatacept, )

    Active, not recruiting
    Has Results
    • Graft vs Host Disease
    • Malignancy
    • Los Angeles, California
    • +13 more
    Jan 9, 2023

    Hypertension Trial in Cincinnati (baxdrostat (formerly CIN-107) oral solution)

    Completed
    • Hypertension
    • baxdrostat (formerly CIN-107) oral solution
    • Cincinnati, Ohio
      Medpace
    Jul 18, 2023

    Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +5 more
    • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
    • (no location specified)
    Aug 23, 2022

    Renal Allograft Recipients Trial in Worldwide (Belatacept, Tacrolimus, Cyclosporine A)

    Recruiting
    • Renal Allograft Recipients
    • Belatacept
    • +5 more
    • Birmingham, Alabama
    • +14 more
    Oct 24, 2022

    Irritable Bowel Syndrome With Diarrhea Trial (CIN-103, Placebo)

    Not yet recruiting
    • Irritable Bowel Syndrome With Diarrhea
    • (no location specified)
    Nov 22, 2023

    Coronary Artery Disease, Nephropathy; Toxic, Drugs Trial (Atorvastatin 80mg, N-acetyl cysteine, Normal Saline)

    Not yet recruiting
    • Coronary Artery Disease
    • Nephropathy; Toxic, Drugs
    • Atorvastatin 80mg
    • +2 more
    • (no location specified)
    Nov 15, 2023

    Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)

    Terminated
    • Hematologic Malignancies
    • Aurora, Colorado
    • +16 more
    Apr 29, 2022

    Chromosomal Instability in Early Diagnosis of Biliary Tract

    Recruiting
    • Biliary Tract Carcinoma
    • The extracted DNA from bile samples will be analyzed by BileCAD to determine the level of CIN.
    • Taizhou, Zhejiang, China
      Taizhou Hospital of Zhejiang Province
    Apr 25, 2023

    Gut Microbiome and Chemotherapy-Induced Nausea in Women

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +3 more
    • Biospecimen Collection
    • Questionnaire Administration
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Jan 4, 2023

    Atopic Dermatitis Trial (Rocatinlimab, Placebo)

    Not yet recruiting
    • Atopic Dermatitis
    • (no location specified)
    Feb 2, 2023

    UCAD for Diagnosing Benign or Malignant Biliary Obstruction and

    Recruiting
    • Biliary Tract Neoplasms
    • +3 more
    • The level of CIN
    • Shanghai, Shanghai, China
      Xinhua Hospital
    Jan 12, 2023

    Diabetic Gastroparesis Trial in United States (CIN-102 Dose 1, CIN-102 Dose 2, Placebo)

    Recruiting
    • Diabetic Gastroparesis
    • CIN-102 Dose 1
    • +2 more
    • Tucson, Arizona
    • +19 more
    Apr 14, 2023

    Cervix Uteri SIL, HPV, CIN2 Trial in Prague (Colposcopy)

    Recruiting
    • Cervix Uteri SIL
    • +3 more
    • Colposcopy
    • Prague, Czechia
      General University Hospital
    Nov 24, 2023

    GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))

    Recruiting
    • Graft Versus Host Disease
    • Ramat Gan, Israel
      Chaim Sheba Medical Center
    May 4, 2022